NR2F2 de-regulation has also been reported in various cancers20–23, where its upregulation correlates with poor clinical outcomes and metastatic progression with effects on angiogenesis, lymphangiogenesis, and tumor growth (reviewed in ref. 24). This evidence concerns the gene NR2F2 and neoplasm.